These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30483809)

  • 1. Chemokine profiling in serum from patients with ovarian cancer reveals candidate biomarkers for recurrence and immune infiltration.
    Mlynska A; Salciuniene G; Zilionyte K; Garberyte S; Strioga M; Intaite B; Barakauskiene A; Lazzari G; Dobrovolskiene N; Krasko JA; Pasukoniene V
    Oncol Rep; 2019 Feb; 41(2):1238-1252. PubMed ID: 30483809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
    Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
    Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the immune microenvironment in ovarian cancer patients.
    Yang L; Wang S; Zhang Q; Pan Y; Lv Y; Chen X; Zuo Y; Hao D
    Mol Omics; 2018 Oct; 14(5):341-351. PubMed ID: 30129640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CXC group chemokines in lung cancer development and progression.
    Spaks A
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S164-S171. PubMed ID: 28446981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Inflammatory CXC Chemokines, GROα
    Cao Y; Huang H; Wang Z; Zhang G
    Immunol Invest; 2017 May; 46(4):361-374. PubMed ID: 28375674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.
    Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A
    Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.
    Gordon-Alonso M; Hirsch T; Wildmann C; van der Bruggen P
    Nat Commun; 2017 Oct; 8(1):793. PubMed ID: 28986561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
    Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
    Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
    Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis.
    Zhuo L; Meng F; Sun K; Zhou M; Sun J
    Br J Cancer; 2024 Oct; 131(6):1068-1079. PubMed ID: 39095528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.
    De La Motte Rouge T; Corné J; Cauchois A; Le Boulch M; Poupon C; Henno S; Rioux-Leclercq N; Le Pabic E; Laviolle B; Catros V; Levêque J; Fautrel A; Le Gallo M; Legembre P; Lavoué V
    Mol Cancer Res; 2019 Dec; 17(12):2537-2548. PubMed ID: 31537619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.
    Gasparri ML; Savone D; Besharat RA; Farooqi AA; Bellati F; Ruscito I; Panici PB; Papadia A
    Tumour Biol; 2016 Jan; 37(1):71-5. PubMed ID: 26500096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of two potential serum biomarkers for ovarian cancer and clinical validation thereof].
    Wang Q; Zhang W; Li DR; Li L
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1012-6. PubMed ID: 18754431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating levels of CXC chemokines is correlated with duration and complications of the disease in type-1 diabetes: a study on Iranian diabetic patients.
    Hakimizadeh E; Shamsizadeh A; Nazari M; Arababadi MK; Rezaeian M; Vazirinejad R; Jamali Z; Poor NM; Khorramdelazad H; Darakhshan S; Hassanshahi G
    Clin Lab; 2013; 59(5-6):531-7. PubMed ID: 23865351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
    Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
    Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
    Bikfalvi A; Billottet C
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients.
    Najmaddini H; Hassanshahi G; Ostadebrahimi H; Barkhordari H; Mashayekhi H; Nazari M; Moogooei M; Arababadi YS; Peighambari F; Karimabad MN
    Ann Saudi Med; 2014; 34(2):122-7. PubMed ID: 24894780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune infiltration profiling in gastric cancer and their clinical implications.
    Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
    Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.